Investors
Scancell Holdings PLC is an AIM listed company
Latest News
Scancell updated Phase 2 data shows continued improvement in progression free survival with iSCIB1+
Welcome to WordPress. This is your first post. Edit or delete it, then start writing!
Scancell to present positive Phase 2 data on Immunobody® iSCIB1+ in late-stage melanoma at SITC 2025
Welcome to WordPress. This is your first post. Edit or delete it, then start writing!